No abstract available
MeSH terms
-
Animals
-
Apoptosis / drug effects
-
Arteriosclerosis / etiology
-
Arteriosclerosis / physiopathology
-
C-Reactive Protein / analysis
-
Cytokines / blood
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / physiopathology
-
Food / adverse effects
-
Gene Expression Regulation
-
Humans
-
Hypercholesterolemia / complications
-
Hypercholesterolemia / physiopathology
-
Hyperinsulinism / complications
-
Hyperinsulinism / physiopathology
-
Hypertension / complications
-
Hypertension / physiopathology
-
Hypertriglyceridemia / complications
-
Hypertriglyceridemia / physiopathology
-
Hypoglycemic Agents / pharmacology
-
Inflammation / complications
-
Inflammation / genetics
-
Inflammation / physiopathology
-
Insulin / pharmacology
-
Insulin / physiology
-
Insulin Resistance
-
Lipoproteins, HDL / metabolism
-
Metabolic Syndrome / complications
-
Metabolic Syndrome / physiopathology*
-
Models, Biological
-
NF-kappa B / metabolism
-
Obesity / complications
-
Obesity / physiopathology
-
Oxidative Stress
-
Plasminogen Activator Inhibitor 1 / blood
-
Rats
Substances
-
Cytokines
-
Hypoglycemic Agents
-
Insulin
-
Lipoproteins, HDL
-
NF-kappa B
-
Plasminogen Activator Inhibitor 1
-
C-Reactive Protein